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a b s t r a c t 
Plaque instability associated with acute coronary syndromes results in part from apoptosis and senescence 
of cells within the atherosclerotic (AS) lesion. Increased cellular oxidative stress has been proposed to con- 
tribute to plaque progression and changes in composition, leading to plaque instability. Our objective was 
to examine the role of NADPH oxidase in smooth muscle cell (SMC) phenotypes associated with an unstable 
plaque. Aortae were isolated from pre-lesion (8 weeks of age) and post-lesion (35 weeks of age) hyper- 
cholesterolemic mice (ApoE −/ −/ LDLR −/ −, AS), and age-matched normal C57BL / 6J mice. We observed an 
age-dependent increase in reactive oxygen species (ROS) in aorta from AS mice, with evidence for elevated 
ROS prior to lesion development. Whereas macrophage inﬁltration was restricted to the lesion, oxidized lipids 
extended beyond the plaque and into the vessel wall. Consistent with these ﬁndings, we observed dynamic 
changes in the expression of NADPH oxidases in AS vessels. Speciﬁcally, Nox1 expression was increased early 
and decreased with lesion progression, while induction of Nox4 was a late event. Nox2 and p22 phox were 
elevated throughout lesion development. Similar to observations in aortae, SMCs isolated from the lesion 
of AS aortae had decreased Nox1 and increased Nox4 levels as compared to SMCs from normal mice. AS
SMCs demonstrated increased generation of ROS, cell cycle arrest, evidence of senescence, and increased 
susceptibility to apoptosis. Overexpression of Nox4 in normal SMCs recapitulated the phenotypes of the AS 
SMCs. We conclude that increased expression of Nox4 in AS may drive SMC phenotypes that lead to the
plaque instability and rupture responsible for myocardial infarction and stroke. 
Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). ntroduction 
Plaque rupture is the primary inciting event in the acute onset of 
yocardial infarction and stroke. Plaque instability is a multifacto- 
ial process that includes increased macrophage content and redox- 
ependent activation of matrix-degrading enzymes that lead to thin- 
ing of the ﬁbrous cap. As a primary source of the supportive extra- 
ellular matrix, loss of smooth muscle cells (SMCs) also contributes to 
laque instability and rupture. A better understanding of the complex 
echanisms that promote plaque rupture may lead to preventative 
trategies. 
Vascular oxidative stress is a mechanistic link between 
acrophage inﬁltration, matrix metalloproteinase activation and 
MC apoptosis in plaque instability. Although there are multiple po- 
ential enzymatic sources of reactive oxygen species (ROS) in vascu- 
ar cells, including xanthine oxidase, lipoxygenase, nitric oxide syn- 
hases, and mitochondrial oxidases [ 1 , 2 ], NADPH oxidases are the * Correspondence to: Department of Internal Medicine, 285 Newton Road, Room 
269 CBRB, Iowa City, IA 52242, USA. 
E-mail address: francis-miller@uiowa.edu (F.J. Miller Jr.). 
213-2317/ $ - see front matter Published by Elsevier B.V. This is an open access article unde
ttp://dx.doi.org/10.1016/j.redox.2014.04.004 primary source of intracellular ROS in atherosclerosis [ 3 ]. Studies us- 
ing mice deﬁcient in catalytic subunits Nox1 or Nox2 or the cytosolic 
subunit p47 phox revealed roles for NADPH oxidase in atherogenesis 
[ 4 –7 ]. However, Nox homolog-speciﬁc changes in gene expression 
occur at different times in disease development. In atherosclerotic 
human coronary arteries, Nox4 expression progressively increases 
from stage I to stage IV disease [ 8 ]. Nox1 expression is increased early 
after wire injury, whereas Nox4 is increased late [ 9 ]. The absence of 
good mouse models has limited new mechanistic insights into plaque 
rupture. 
SMCs contained within the lesion are phenotypically distinct from 
medial contractile SMCs [ 10 , 11 ]. In this study, our objective was to 
examine the contribution of NADPH oxidase in plaque-derived SMCs. 
Our data identify a relationship between Nox4 expression and lesion 
progression, ROS levels, apoptosis, and cell cycle arrest. These results 
implicate Nox4 in senescence and apoptosis of plaque-derived SMCs, 
suggesting an integral role for Nox4 in plaque stability. r the CC BY-NC-ND license ( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
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 Methods 
Ethics statement 
This study was carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was approved by the
University of Iowa Animal Care and Use Committee (ACURF Protocol
number: 0208216). 
Animals 
Studies were performed in normal (C57BL / 6J) and hypercholes-
terolemic (ApoE and LDL receptor deﬁcient) mice fed a normal chow
diet. Double homozygous ApoE and LDL-receptor deﬁcient mice are
> 10 generation hybrids (C57BL / 6J background) originally obtained
from Jackson Laboratory. Mice were studied at 8 weeks (prelesion)
and 24–35 weeks (established lesions) of age. 
Cell culture 
Vascular smooth muscle cells were isolated from the media of nor-
mal (C57Bl / 6J) aorta or atherosclerotic intima of ApoE / LDL receptor-
deﬁcient aorta with minor modiﬁcation of methods previously de-
scribed [ 10 , 12 ]. Multiple aorta from mice 24–35 weeks of age were
pooled for isolation of SMCs. In brief, animals were euthanized with
pentobarbital (150 mg / kg i.p.) and aortae were removed under ster-
ile conditions, cleaned of adventitia, opened longitudinally, and incu-
bated in DMEM supplemented with fungizone (2.5 μg / mL), penicillin
G (10,000 U / dL), and streptomycin (10,000 U / dL). After 4 h, the tissue
was transferred to phosphate buffered saline (PBS) containing type 1
collagenase (2 mg / mL) at 37 ◦C for 20 min. The control aorta segment
was then scraped to remove remaining endothelium. In atheroscle-
rotic aorta, the intima was microdissected from the medial layer.
Tissue was cut into 1-mm strips and incubated in collagenase (2 mg /
mL), elastase (0.5 mg / mL), and bovine serum albumin (1 mg / mL) for
40 min. Cell suspensions were centrifuged, the pellet resuspended in
DMEM containing 10% fetal bovine serum (FBS), and cells plated on
collagen-treated surfaces. After 24 h, medium was removed, and cells
were rinsed with DMEM to remove debris. Growth media consisting
of DMEM containing 10% FBS was changed twice weekly and cells
were used for experiments at 90–100% conﬂuence. All studies were
performed on cells from the fourth to eighth passages. For each pas-
sage, cells were identiﬁed as SMCs by positive immunohistochemical
staining for smooth muscle α-actin. Studies were performed in four
different isolations of AS and normal SMCs. Human coronary artery
SMCs (HCASMCs) were purchased from ATCC and cultured in Vascular
Cell Basal Media (ATCC) supplemented with Vascular Smooth Muscle
Growth Kit components (ATCC). 
Real-time quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated from SMC using TRI reagent (Molec-
ular Research Center, Inc.) and treated with DNase I (Ambion)
to remove contaminating DNA. First-strand cDNA synthesis
was performed using total RNA, random hexamer, dNTP, and
superscript II reverse transcriptase (Invitrogen). Relative lev-
els of p22 phox , Nox1, Nox2 and Nox4 mRNA were quantiﬁed
with real-time, quantitative PCR using the QuantiTect SYBR
green I PCR kit (Qiagen) in a PerkinElmer 7000 real-time ther-
mocycler as previously described [ 13 ]. Primer sequences are
as follows: Nox1 forward 5 ′ -CATCCAGTCTCCAAACATGACAG-
3 ′ , reverse 5 ′ -TGCAACTCCCCTTATGGTCATC-3 ′ ; Nox2forward 5 ′ - CAGGAACCTCACTTTCCATAAGATG-3 ′ ; re-
verse 5 ′ -AACGTTGAAGAGATGTGCAATTGT-3 ′ ; Nox4 for-
ward 5 ′ -CTGGTCTGACGGGTGTCTGCATGGTG-3 ′ , reverse 5 ′ -
CTCCGCACAATAAAGGCACAAAGGTCCAG-3 ′ ; p22 phox forward
5 ′ -AGATCGAGTGGGCCATGTGGGCCAACGAAC-3 ′ , reverse 5 ′ -
CTTGGGTTTAGGCTCAATGGGAGTCCACTGCTCA-3 ′ . Data were
normalized to 18S rRNA (Alternate 18S Internal Standards, Ambion). 
ROS measurements 
Superoxide levels in vessels 
Aortic segments (3 mm) were obtained from the aortic arch, rinsed
in cold PBS, ﬂash frozen in OCT, sectioned (30 μm), and incubated in
dihydroethidium (DHE, 10 μM, Molecular Probes) for 30 min at 37 ◦C
as previously described [ 12 ]. DHE ﬂuorescence in aortic sections was
detected with a Zeiss LSM 510 META confocal microscope (excita-
tion, 514 nm; emission, 575 nm long pass ﬁlter). Where indicated,
sections were preincubated with polyethylene glycolated superoxide
dismutase (PEG-SOD, 500 units / mL) prior to DHE. 
Intracellular superoxide and H 2 O 2 in cells 
Intracellular superoxide and H 2 O 2 levels were detected in
SMCs with dihydroethidium (DHE) or 5-(and-6)-chloromethyl-2 ′ ,7 ′ -
dichlorodihydroﬂuorescein diacetate, acetyl ester (CM-H2DCFDA),
respectively as described previously [ 13 ]. Brieﬂy, cells were treated
with DHE (10 μM) or CM-H2DCFDA (20 μM) for 30 min at 37 ◦C. DHE
ﬂuorescence intensity was visualized with Zeiss LSM 510 META laser
confocal microscope and quantitated with NIH ImageJ software. In
each experiment, 7–8 randomly picked ﬁelds per sample (29–54 cells
in each ﬁeld) were visualized and captured. 2 ′ ,7 ′ -dichloroﬂuorescein
intensity was determined on a Becton Dickinson FACScan (BD Bio-
sciences) and analyzed with the FlowJo software package (Tree Star,
Inc.). Data were normalized to cell number. Because both DHE and
dichloroﬂuorescein ﬂuorescence is known to have limitations regard-
ing speciﬁcity for detection of superoxide and peroxides, respectively
[ 14 ], we performed the additional measurements of ROS. 
Extracellular H 2 O 2 in cells 
Cells were incubated with Amplex Red (50 μM) and HRP (1 U /
mL) for 1 h, after which the ﬂuorescence intensity of the media was
determined (excitation and emission wavelengths of 545 and 590 nm,
respectively) and normalized to cell number as previously described
[ 15 ]. 
NADPH-stimulated superoxide 
Membrane-enriched fractions were isolated as previously de-
scribed [ 16 ]. Brieﬂy, cells were lysed by sonication in ice-cold pro-
tease inhibitor buffer, centrifuged at 500 g for 10 min at 4 ◦C to re-
move cell debris, and then the supernatant centrifuged at 100,000 g
for 60 min at 4 ◦C. The pellet was suspended in protease inhibitor
buffer and protein concentration measured. NADPH oxidase activity
of 20 μg protein was measured by lucigenin-enhanced chemilumi-
nescence (5 × 10 −6 M) after addition of NADPH (10 −4 M). Duplicate
samples were also incubated with catalase (250 units / mL) and the
catalase-inhibitable chemiluminescence was measured in an FB12 lu-
minometer (Zylux Corp) and RLU / sec normalized to protein. Where
indicated, cells were treated with 0.1 mM diphenyleneiodonium (DPI)
prior to lysis. 
Immunohistochemistry 
Oxidized phospholipids were assessed in aortic sections using IgM
E06 (1:400 dilution) followed by appropriate secondary antibody and
avidin-biotin-AP complex as previously described [ 17 ]. E06 binds the
phosphocholine head group of oxidized but not native phospholipids.
For macrophage immunostaining, sections were blocked with serum
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 nd incubated overnight at 4 ◦C with mouse macrophage antigen 
MOMA)-2 (Accurate Chemicals, 1:100), then with biotinylated im- 
unoglobulin followed by avidin–biotin–AP complex and visualized 
ith Vector Red alkaline phosphatase substrate (Vector Laboratories). 
o staining was seen when serial sections were treated with nonim- 
une sera instead of primary antibody. 
easurement of antioxidant activities 
Superoxide dismutase (SOD) activities were measured as de- 
cribed previously [ 18 ]. One unit of SOD activity was deﬁned as the 
mount of protein that yields 50% of maximal inhibition of nitrob- 
ue tetrazolium reduction by superoxide. Catalase activity was deter- 
ined by monitoring the disappearance of H 2 O 2 and expressed in κ
nits / mg protein [ 19 ]. 
-Galactosidase 
β-Galactosidase activity was measured in extracts from SMCs 
ultured under normal growth conditions using the Galacto-Light 
lus Chemiluminescence reporter assay kit (#BL100P, Applied Biosys- 
ems) per the manufacturer’s instructions. Data are expressed as rel- 
tive light units (RLU) per min and normalized to protein concentra- 
ion. 
ell growth 
SMCs at passage 4 were plated at equivalent densities (10 4 cells / 
ish) in 6-well plate and cultured in standard growth medium with 
0% FBS for 6 days. Cell counts were performed 6 h after plating (day 0) 
o ensure equivalent efﬁciency for both SMC. At intervals after plating, 
ells were trypsinized, and cell numbers were determined using a 
oulter Counter. Cell proliferation was also examined as described 
reviously by measuring incorporation of [ 3 H]-leucine [ 10 ]. Brieﬂy, 
ells were serum-starved in 0.5% FBS for 72 h, and then were either 
aintained in 0.1% FBS or cultured in standard growth medium with 
0% FBS supplemented with [ 3 H]-leucine for 24 h. Data are expressed 
t counts per minute (CPM). 
ell cycle analysis 
Normally cycling cells were incubated with 10 μM 5-bromo-2 ′ - 
eoxyuridine (BrdU) for 30 min, trypsinized, and ﬁxed 70% ice-cold 
thanol. Fixed cells were incubated in 0.2 mg / mL pepsin prepared 
n 2 N HCl for 30 min, and then neutralized with 0.3 M borax. Cells 
ere next incubated in anti-BrdU primary antibody (BD Biosciences) 
ollowed by FITC-conjugated secondary antibody. Cells were then 
reated with 1 mg / mL RNase A for 30 min then incubated with 
7.5 μg / mL propidium iodide for 60 min. Cells were then analyzed on 
 FACScan (Becton Dickinson) using the CELLQUEST ﬂow cytometric 
nalysis software (BD Biosciences) and ModFit (Verity) was used to 
nalyze cell cycle alterations. 
estern blot analysis 
Cells were lysed in lysis buffer containing 62.5 mM Tris, pH 6.8, 
% SDS, 10% glycerol, and 50 mM diethylenetriaminepentaacetic acid 
DTT). After sonication, protein concentration was determined and 
0 μg protein was subjected to SDS-PAGE, transferred to nitrocellu- 
ose membranes, blocked with 5% milk, and incubated with primary 
ntibodies (1:1000 anti-cyclin D1: #2926 Cell Signaling; 1:500 mouse 
onoclonal anti-retinoblastoma protein: BD Biosciences; 1:10,000 
ouse monoclonal anti- β-actin: Sigma) and HRP-conjugated sec- 
ndary antibodies. Bands were visualized using SuperSignal West Pico 
hemiluminescent Substrate from Pierce. TUNEL staining 
Mice were euthanized by intraperitoneal (IP) injection of pento- 
barbital (50 mg / kg) and aorta removed and dissected free of loosely- 
adhering tissue. A section of the thoracic aorta was snap-frozen aorta 
and sectioned (8 μm thick). Terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) staining was performed on aortic 
sections using the Apop-Tag In Situ Apoptosis Detection kit (Milli- 
pore) according to the manufacturer’s instructions. 
Apoptosis 
Apoptosis was assessed using the Vybrant Apoptosis Assay kit 
(V-13242, Molecular Probes) per manufacturer ’ s instructions. Brieﬂy, 
cells were centrifuged and resuspended in annexin-binding buffer 
(140 mM NaCl, 2.5 mM CaCl 2 , 10 mM HEPES, pH 7.4), stained with 
FITC-conjugated annexin V and propidium iodide, and incubated for 
15 min at room temperature. Cells were then analyzed on a FACScan 
(Becton Dickinson) using the CELLQUEST ﬂow cytometric analysis 
software (BD Biosciences). Cells in the lower right dot plot quadrant 
(PS-positive and PI-negative) were reported as apoptotic, whereas 
cells in the upper right dot plot quadrant (PS-positive and PI-positive) 
were scored as necrotic. For normal (C57Bl6 / J) primary aortic SMCs 
infected with Ad-Nox4 and treated with H 2 O 2 , 48 h after infection 
cells were serum-starved in the presence or absence of 50 μM H 2 O 2 
for 24 h prior to assessment of apoptosis as described. All other apop- 
tosis measurements were obtained using cells cultured in serum- 
containing normal growth media. 
Cell viability 
Cells were treated with increasing concentrations of H 2 O 2 for 
24 h in serum-free media, and then cell viability determined using 
the CellTiter 96 AQueous One Solution 3-(4,5-dimethyl-2-yl)-5-(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
Assay (Promega) per the manufacturer’s instructions. 
Nox4 knockdown 
Nox4 siRNAs were generated from gene speciﬁc double-stranded 
RNA (dsRNA) and transfected into AS SMC using Dicer siRNA Gen- 
eration Kit (Gene Therapy Systems) according to the manufacturer’s 
instructions. In brief, a plasmid containing murine Nox4 cDNA 
(kindly provided by Dr. Kathy Griendling, Emory University) was 
used as template for PCR. Primer sequences: forward primer: 5 ′ - 
GCGTAATACGACTCACTATAGGGAGAATGCATTTGGCTGTCCCTAAACG- 
3 ′ ; reverse primer: 5 ′ -GCGTAATACGACTCACTATAGGGAGATAAAACAA
ACCACCTGAAACATGC-3 ′ . The PCR product was transcribed to dsRNA 
then digested with recombinant Dicer enzyme to generate siRNA 
duplexes. After puriﬁcation and quantiﬁcation, plaque-derived SMC 
were transfected with 200 nM siRNA using GeneSilencer siRNA 
transfection reagent. GFP siRNA served as negative control. 
Nox4 overexpression 
Senescence experiments 
To generate pCMV-Nox4, full-length human Nox4 cDNA (kindly 
provided by J. David Lambeth, Emory University) was cloned into 
pCMV-Script after excising Nox4 cDNA from pcDNA3 by restriction 
digestion with KpnI and NotI, blunting, and insertion into pCMVscript 
by blunt end ligation. HCASMCs were transfected with either pCMV- 
Script empty vector or pCMV-Script containing Nox4 cDNA using 
Lipofectamine (Invitrogen). Experiments were performed 48 h after 
transfection. 
S. Xu et al. / Redox Biology 2 (2014) 642–650 645 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Apoptosis experiments 
The University of Iowa Gene Transfer Vector Core directionally
cloned Nox4 cDNA from pCMV-Nox4 into the replication deﬁcient
recombinant adenoviral vector containing CMV, Ad5CMV, to gener-
ate Ad-Nox4. The vector was sequenced for conﬁrmation. All ade-
noviruses were generated by the University of Iowa Gene Transfer
Vector Core. Normal (C57Bl6 / J) primary aortic SMCs were infected
with Ad-Nox4 or Ad-GFP at multiplicity of infection (MOI) of 300 in
serum-free media in the presence of cationic polymer poly-l-lysine
(250 molecules / virus particle) as previously described [ 20 ]. After 6 h,
fresh 10% FBS-containing medium was added, and experiments were
conducted 48 h after infection. 
Statistical analysis 
Results are expressed as mean ± SEM. Statistical comparisons
were performed by one-way or two-way analysis of variance (ANOVA)
with appropriate post-hoc analysis. For analysis of Nox mRNA levels
in vessels, the one sample t -test was used. For cell viability assays in
the presence of H 2 O 2 , analysis was performed with two-way repeated
measures ANOVA with Bonferroni post-test. A p value of < 0.05 was
considered signiﬁcant. 
Results 
Increased superoxide production precedes lesion formation in 
atherosclerotic aortae 
Using the ApoE −/ −/ LDLR −/ − mice as a model of atherogenesis,
we ﬁrst evaluated the time-dependent increase in superoxide levels
in aorta of AS mice as compared to normal C57BL / 6J mice. As pre-
viously reported, superoxide levels were increased in aorta after the
development of atherosclerotic plaques ( Fig. 1 A, AS 35 weeks). In-
terestingly, the increase in superoxide levels preceded development
of lesions (AS 8 weeks). This early increase in cellular superoxide
appeared primarily along the endothelial layer and within the ad-
ventitia. Pre-incubation of AS 35 weeks aortic sections with antioxi-
dant superoxide dismutase (PEG-SOD) normalized superoxide levels
to those observed in C57BL / 6J mice ( Fig. 1 A). Thus, an early indicator
in atherogenesis is an increase in superoxide levels, which precede
the development of atherosclerotic lesions. 
In the aortic sinus, the distribution of oxidized phospholipids ex-
tended into the vessel wall ( Fig. 1 B), whereas macrophage inﬁltration
was in general restricted to the plaque ( Fig. 1 C). This observation sug-
gests that the increased superoxide is not limited to macrophages but
is derived from enzymatic sources within the vessel wall. 
Variable NADPH oxidase expression with atherogenesis 
NADPH oxidases are the primary source of superoxide in the vessel
wall. We next determined the relationship between NADPH oxidase
expression and development of atherosclerosis. In the AS aorta prior
to lesion development (AS 8 weeks), mRNA levels of p22 phox , Nox1
and Nox2 but not Nox4 were increased as compared to aorta from
normal C57BL / 6J mice ( Fig. 2 A). By 24 weeks of age, Nox1 levels were
no longer increased, whereas Nox2 levels remained elevated ( Fig.
2 B). In contrast to the pre-lesion, Nox4 levels were also increased by
24 weeks. The dynamic changes in Nox1 and Nox4 expression suggest
distinct functional contributions of these subunits in atherosclerosis.
Cultured AS SMCs have increased NADPH oxidase activity 
The primary cellular component of the vascular wall is SMCs. In
response to activation, SMCs migrate to the subendothelial space and
proliferate, contributing to lesion formation. Within the atheroscle-
rotic lesion, SMCs provide extracellular matrix deposition and plaquestability. Based on our observations of dynamic changes in Nox1 and
Nox4 in the aorta during atherogenesis, we next focused our stud-
ies on SMCs, which express both of these subunits. SMCs were iso-
lated and cultured from aorta of AS mice ( > 24 weeks of age) or from
C57Bl6 / J (normal) aorta. Consistent with our observations in AS aorta
(24 weeks), Nox1 levels in SMCs derived from AS aorta were ˜ 1.5-fold
lower whereas levels of both Nox4 and p22 phox were 3-fold higher
as compared to normal SMCs ( Fig. 3 A). NADPH oxidase activity, as
measured by NADPH-stimulated superoxide, was greater in AS SMCs
as compared to normal SMCs. Superoxide generation was prevented
by the ﬂavoenzyme inhibitor diphenyleneiodonium (DPI, Fig. 3 B). We
next measured ROS levels and observed signiﬁcantly higher intracel-
lular superoxide and H 2 O 2 levels as well as extracellular H 2 O 2 in AS
SMCs relative to normal SMCs ( Fig. 3 C–E). Knockdown of Nox4 in AS
SMCs decreased intracellular ROS levels by 40% (siNox4: 168 + / −16;
siGFP: 265 + / −17 RFU / cell normalized to normal SMCs, p < 0.05).
Antioxidant activity was also elevated in AS SMCs, with a 3.67 ± 0.07-
fold increase in Cu 2 + / Zn + SOD, a 2.15 ± 0.15-fold increase in Mn 2 + 
SOD, and a 2.87 ± 0.14-fold increase in catalase ( n = 4; * p < 0.05 vs.
normal SMCs), in accord with increased antioxidative enzyme expres-
sion in human atherosclerotic lesions [ 21 ]. These data are consistent
with the hypothesis that increased cellular ROS in AS SMCs results
from increased NADPH oxidase activity, in particular Nox4. 
Nox4 mediates a senescent phenotype in AS SMCs 
Redox-dependent activation of SMCs by NADPH oxidases pro-
motes cell growth [ 3 ]. Therefore, we compared growth in normal
and AS SMCs and found that, over 6 days of culture in complete
media, the number of AS SMCs was dramatically lower than nor-
mal SMCs ( Fig. 4 A). Conﬁrming a decrease in DNA synthesis, [ 3 H]-
thymidine incorporation was impaired in AS SMCs as compared to
normal SMCs ( Fig. 4 B). H 2 O 2 has been shown to induce replicative
senescence as demonstrated by an increase in senescence-associated
β-galactosidase activity and cell cycle arrest [ 22 , 23 ]. Analysis of β-
galactosidase activity revealed a 1.9-fold increase in AS SMCs relative
to normal SMCs (574 + / −39 vs. 306 + / −11 RLU / min / mg, respec-
tively, n = 4, p < 0.01). In addition, we observed an increased per-
centage of AS SMCs in G0 / G1 ( Fig. 4 C and D), consistent with previ-
ous reports that atherosclerotic plaque-derived SMCs have a senes-
cent phenotype [ 11 ]. The AS SMC arrest in G0 / G1 corresponded with
decreases in cyclin D1and retinoblastoma protein (Rb, Fig. 4 E). To
evaluate the contribution of Nox4 to the senescent phenotype in AS
SMCs, we attempted to restore cell cycle progression by knocking
down Nox4. Despite a 40% reduction in intracellular H 2 O 2 levels, the
knockdown of Nox4 failed to release cells from G0 / G1 arrest (data not
shown). This observation is consistent with senescence representing
terminal differentiation, and the loss of proliferative potential is irre-
versible [ 24 ]. Therefore, we next determined the potential for Nox4 to
induce a senescent-like phenotype by overexpressing Nox4 in normal
SMCs. We conﬁrmed that overexpression of Nox4 increased cellular
H 2 O 2 by greater than 2-fold ( Fig. 4 F). Nox4 overexpression induced
an increase in the percentage of cells in G0 / G1 and a decrease in S
phase ( Fig. 4 G), indicative of cell cycle arrest in G0 / G1. These data
provide evidence for a role for Nox4 in the senescent phenotype in AS
SMCs. 
Nox4 contributes to increased susceptibility of AS SMCs to cell death 
Apoptosis is increased in multiple cell types in atherosclerotic le-
sions [ 25 ]. In AS vessels, we observed increased TUNEL staining within
the lesion relative to the adjacent medial layer ( Fig. 5 A). In isolated
SMCs cultured in full serum, more than 10% of AS SMCs were apop-
totic ( Fig. 5 B). We next examined the effect of oxidative stress on
cell viability and found that, with increasing concentrations of exoge-
nous H 2 O 2 , AS SMCs had reduced viability as compared to normal
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Fig. 1. Increased aortic superoxide levels precede lesion development in hypercholesterolemic mice. (A) Confocal ﬂuorescent images of DHE-stained aortic cross-sections from 
normal (C57) or hypercholesterolemic ApoE −/ −LDLR −/ − (AS) mice. White arrows denote the endothelial layer; arrowhead denotes plaque. Scale bar = 100 μm. Right panel, 
summary data of DHE ﬂuorescence in the absence or presence of PEG-SOD (SOD). Data were normalized to vessel area. RFU, relative ﬂuorescent units. n = 4, * p < 0.05 vs. C57 at 
35 weeks; + p < 0.05 vs. AS at 35 weeks. (B and C) Oxidized phospholipids (B) and macrophage inﬁltration (C) was examined by immunohistochemistry in the aortic sinus of AS 
mice at 35 weeks of age. The open red arrows indicate staining of oxidized lipids (B) and macrophages (C). The no primary controls showed no staining (not shown). 
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Fig. 2. NADPH oxidase subunits are differentially expressed in pre-lesion and post-lesion aorta. Relative mRNA expression as determine by qRT-PCR in aorta from AS mice at 8 (A) 
and 24 (B) weeks of age. Data were normalized to 18S RNA and quantitated as the percent change in expression in aorta from normal age-matched C57 mice ( n = 4). * p < 0.05 vs. 
C57. 
Fig. 3. Isolated AS SMCs have increased NADPH oxidase expression and activity. (A) Percent change in mRNA expression in AS SMCs relative normal C57 SMCs. (B) NADPH oxidase 
activity in normal C57 (normal) or AS SMCs as indicated by the NADPH-stimulated lucigenin-enhanced chemiluminescence in the absence or presence of 100 μM DPI. Data were 
normalized to protein concentration. RLU, relative light units. (C and D) Intracellular superoxide (O 2 
−• , C) and H 2 O 2 (D) levels as determined by ﬂow cytometry after DHE or DCFH 
staining, respectively. (E) Extracellular H 2 O 2 levels as determined by Amplex Red. n = 4–10 Experiments. * p < 0.05 vs. normal SMCs; + p < 0.05 vs. untreated AS SMCs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SMCs ( Fig. 5 C). Addition of the ﬂavoenzyme inhibitor DPI improved
AS SMCs viability in the presence of H 2 O 2 ( Fig. 5 D). Furthermore,
overexpression of Nox4 in normal SMCs increased apoptosis under
normal growth conditions ( Fig. 5 E) and in response to H 2 O 2 ( Fig. 5 F).
These data suggest that the observed increased in Nox4 expression in
AS SMCs contributes to the increased susceptibility to apoptosis. 
Discussion 
Previous studies from patients with established coronary artery
disease demonstrate differential expression of NADPH oxidase sub-
units [ 8 , 26 ]. Our objective was to evaluate the changes in NADPH
oxidases with progression of atherosclerosis. Studies in AS micedemonstrated a prelesional increase in Nox1, whereas development
of plaque was associated with increased expression of Nox4. SMCs iso-
lated from AS aorta showed a decrease in growth, G0 / G1 arrest with
corresponding alterations in cell cycle regulators, and increased levels
of the senescence marker β-galactosidase. Furthermore, AS SMCs had
decreased viability and increased susceptibility to apoptosis. Similar
phenotypes were observed with overexpression of Nox4 in normal
SMCs. Together, our data implicate Nox4 in SMC growth inhibition,
apoptosis, and senescence, processes that are known to contribute to
plaque destabilization and myocardial infarction. 
A number of studies have evaluated the role of NADPH oxidases in
atherogenesis. Early evidence for increased NADPH oxidase in lesions
came from examination of p22 phox expression in human coronary
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Fig. 4. Overexpression of Nox4 in normal SMCs mimics the senescent phenotype observed in AS SMCs. (A) Cell growth in 10% FBS as determined by cell number. * p < 0.05 vs. 
normal SMCs. (B) Cell growth in 0.1% (left panel) or 10% FBS (right panel) as determined by [ 3 H]-leucine uptake. Data are reported as counts per minute (CPM). * p < 0.05 vs. 
normal SMCs. (C) Representative cell cycle proﬁles. (D) Quantitation of cell cycle distribution. * p < 0.05 vs. normal SMCs in same cell cycle phase. (E) Expression of G0 / G1 cell 
cycle markers by Western blotting. (F) H 2 O 2 levels as determined by DCFH staining and ﬂow cytometry in HCASMCs transfected with either control plasmid (control) or plasmid 
containing Nox4 cDNA (Nox4). * p < 0.05 vs. control. (G) Quantitation of cell cycle distribution in HCASMCs transfected with control or Nox4 plasmid. * p < 0.05 vs. control in same 
cell cycle phase. n = 3–5 Independent experiments. 
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ubsequent studies demonstrated that Nox2 but not Nox1 is also 
ncreased in advanced human atherosclerotic lesions [ 8 , 26 ]. In non- 
uman primates on an atherogenic diet, both Nox1 and Nox2 levels 
re increased and return to baseline with normal diet [ 28 ]. Genetic 
eﬁciency of p47 phox , Nox1, and Nox2 are all associated with protec- 
ion against lesion development in ApoE −/ − AS mice [ 4 –7 ]. However, 
 limitation of these genetic mouse models is they are designed to 
rimarily examine the role of NADPH oxidase in the initiation and 
arly progression of atherogenesis. A strength of our study is that we 
eﬁne the temporal changes in NADPH oxidases and identify a role 
or SMC Nox4 in the later stages of atherosclerosis, in particular the 
laque phenotypes of apoptosis and senescence. Administration of 
 dual Nox1 / Nox4 pharmacologic inhibitor (GenKyoTex) reduces le- 
ion area, ROS generation, and markers of oxidative stress in AS mice [ 29 ]. Consistent with the role of Nox4 in plaque phenotypes rather 
than plaque formation, it has been recently demonstrated that de- 
ﬁciency of Nox4 on an ApoE −/ − model does not impact lesion area 
[ 30 ]. 
Recent reports suggest a protective effect for Nox4-derived H 2 O 2 
in the vasculature [ 31 –33 ]. Whereas these studies have primarily fo- 
cused on the role of Nox4 in endothelial cells, it is unclear whether 
increased expression of Nox4 in SMCs is protective. Based on our data, 
Nox4 mediates changes in cell growth, apoptosis, and senescence of 
SMCs. Together, these observations imply that Nox4-derived H 2 O 2 
is necessary for signaling adaptive survival pathways; however, in- 
creased Nox4 expression in SMCs can lead to oxidative stress and be 
detrimental. Consistent with this interpretation, others have shown 
using a model of ischemic stroke that the absence of Nox4 is neuro- 
protective [ 34 ]. 
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Fig. 5. Overexpression of Nox4 in normal SMCs mimics the apoptotic phenotype observed in AS SMCs. (A) Representative TUNEL staining of aortic sections from 24-week old AS 
mice. Arrow indicates lesion. (B) Percent apoptotic cells as determined by propidium iodide and annexin V staining of normal or AS SMCs cultured in 10% FBS ( n = 7–10). (C) Cell 
viability as determined by MTS assay in the absence or presence of increasing concentrations of H 2 O 2 in 0.5% FBS for 24 h. Data were quantitated relative to normal SMCs without 
H 2 O 2 ( n = 4). * p < 0.05 normal vs. AS by two-way repeated measures ANOVA with Bonferroni post-test. (D) Cell viability as measured by MTS assay in serum-starved cells treated 
with 50 μM H 2 O 2 in the presence or absence of 10 μM DPI for 24 h. Data were quantitated relative to normal SMCs without H 2 O 2 ( n = 4). (E) Percent apoptotic cells as determined 
by annexin V / propidium iodide staining of normal SMCs infected with either Ad-GFP (control) or Ad-Nox4 (Nox4) for 48 h ( n = 7). (F) Percent apoptotic cells after infection of 
normal SMCs with either Ad-GFP (control) or Ad-Nox4 (Nox4) and treatment 48 h later with 50 μM H 2 O 2 in 0.5% FBS for 24 h ( n = 5–6). * p < 0.05 vs. normal SMCs (B–D) or control 
adenovirus (E and F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We observed an increase in Nox1 expression prior to the develop-
ment of overt plaque, which is consistent with Nox1 activation in the
early response to vascular injury [ 4 , 9 ]. Nox2 levels remained elevated
throughout the disease continuum, reﬂecting the predominant con-
tribution of inﬂammatory cells in the atherosclerotic lesion [ 35 ]. Data
regarding changes in Nox4 expression in late stage atherosclerosis in
human and non-human primates have been inconclusive [ 26 , 28 , 36 ].
In our AS murine model, we observed an increase in Nox4 mRNA levels
in advanced lesions. Importantly, the relative changes in Nox4 were
more pronounced when measured in AS SMCs ( Fig. 3 A) as compared
to the total AS vessel ( Fig. 2 B). This observation may in part explain
the failure of prior studies to show changes in Nox4 since plaque SMCs
only represent a small proportion of the total SMCs in an intact vessel.
The observed temporal changes in Nox1 and Nox4 expression during
atherogenesis suggest distinct functional consequences of the Nox-
derived ROS. Whereas Nox1-derived ROS are important in SMC mi-
gration and proliferation [ 10 , 37 ], our data suggest the Nox4-derived
ROS contribute to SMC growth inhibition, apoptosis, and senescence. 
Since SMCs contribute to the stability of the ﬁbrous cap in part by
synthesizing extracellular matrix, apoptosis of SMCs has been pro-
posed as a mechanism for plaque instability and rupture [ 38 ]. Treat-
ment of cultured SMCs with 7-ketocholesterol, an oxysterol present
in oxidized LDL, induces apoptosis through increased expression of
Nox4 [ 39 ]. Our ﬁndings take this a step further by providing evidence
for Nox4-dependent apoptosis in atherosclerosis. Our study was not
designed to look for evidence of plaque rupture in vivo in large part
because the animal models have poorly mimicked plaque instability
and the formation of occlusive thrombi [ 38 ]. 
In addition to apoptosis, senescence is a hallmark of SMCs within
an advanced lesion. Characteristic changes in human plaque SMCs
include hypo-phosphorylation of Rb, increased expression of cyclin-
dependent kinase inhibitors, and decreased expression of cyclins [ 24 ].
 In addition to cell cycle alterations, senescence is also evidenced by
β-galactosidase expression [ 24 ]. We observed many of these changes,
speciﬁcally hypo-phosphorylation of Rb, decreased expression of cy-
clin D1, increased expression of β-galactosidase, and G0 / G1 arrest,
SMCs derived from a murine model of AS. Furthermore, we found
that overexpression of Nox4 in normal SMCs mimicked the cell cy-
cle arrest observed in AS SMCs. These ﬁndings are consistent with
recent evidence that Nox4 contributes to a senescent phenotype in
endothelial cells [ 40 ]. The knockdown of Nox4 in AS SMCs was un-
successful in restoring normal cell cycle progression. However, this
not unexpected given that replicative senescence is a terminal phe-
notype [ 24 ]. Whereas our data do not identify the speciﬁc mechanism
for increased Nox4 expression in the AS SMCs, it has been reported
that TGF- β levels are increased in advanced atherosclerotic lesions
[ 24 ]. TGF- β is known to induce Nox4 expression in SMCs [ 41 ]. 
Conclusions 
Vascular cells in AS are known to have a senescent phenotype with
increased susceptibility to apoptosis, thereby predisposing to plaque
rupture with subsequent thrombosis and myocardial infarction. Novel
ﬁndings from this study show a similar phenotype in SMCs derived
from a murine model of AS and implicate the Nox4 NADPH oxidase
in these phenotypic changes. These data provide new insight into the
enzymatic source of ROS in advanced AS. 
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